Successful Treatment of Lower Eyelid Melanoma in Situ
- Andrew A. Gassman, MD
- Joyce Yuan, MD
- Justin Koh, BA
- Timothy A. Miller, MD, FACS
Publication date
May 2014
DOI Publisher
Wolters Kluwer ISSN
2169-7574 Journal
issn:2169-7574Abstract
Summary: We present a brief literature review of the topical immune-modulating medication Imiquimod. The treatment of periorbital melanoma in situ typically requires surgical resection. Here we discuss a case of lower eyelid melanoma in situ successfully treated non-operatively with Imiquimod
Add to ORKG